FFPE samples of primary, resectable tumors from patients with HNSCC (N = 44), BC (N = 48) and CRC (N = 48) were evaluated for CD47 expression by IHC (Figure 1A). The gene discussed is CD47; the disease is head and neck squamous cell carcinoma.